IDH2 mutation associated with favourable outcome in older adults with newly diagnosed ALL treated with lower-intensity therapy

Demographics, characteristics, survival and outcomes in older, untreated, AML with NPM1 mutations or KMT2A rearrangements

Bladder cancer updates from the second half of 2024

Multiple Myeloma: evolving paradigm - Panel Discussion

Head & Neck - BMC Data

Choosing the right patients for transplant

CAR-T - Choosing Wisely

Choosing Wisely for young women with breast cancer: BMC data

Choosing Wisely in endometrial & cervix cancers: BMC data

ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer

Cancer mutation prediction using artificial intelligence

Biomarkers, predictive and prognostic factors of resistance to immunotherapy